Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of December 21st – 27th, 2020.

Without further ado, let’s get started.

Yahoo Finance readers, please click here to view the full article.

10. 2020 Was The Year of Psychedelics — Here’s Why

While Many 2020 Memories Will Be Gladly Left Behind, That’s Not Necessarily the Case For Psychedelics

There was an unprecedented renaissance as Psychedelic compounds, and their potential to treat mental health conditions became one of the centrepieces of this year’s public conversation. Psychedelic companies — those researching and producing these compounds — jumped into the spotlight of investment markets, with almost two dozen Psychedelics companies going public between February and December. Here are five of the most noteworthy Psychedelic Stock IPOs of 2020:

READ FULL 2020 PSYCHEDELICS ARTICLE

9. What Trump’s Pardon Means For This Man Who Served 13 Years in Prison For Marijuana

Weldon Angelos Got the Call From Sen. Mike Lee (R-UT) on Tuesday and Broke Down in Joy After Learning He Had Just Received a Presidential Pardon for a Federal Marijuana Conviction That Cost Him Over a Decade in Prison

Since having his sentence reduced and being released from a mandatory minimum sentence in 2016, Angelos has committed himself to advocating for criminal justice reform. He’d served 13 years, and he knows intimately the inequities of the system. Now, a GOP senator told him on the other end of the phone, that, thanks to President Trump’s pardon, his conviction—and the lingering consequences it has on his life—are null and void.

READ FULL TRUMP PARDON ARTICLE

8. Psychedelic Drug DMT Could ‘Revolutionise’ How We Treat Depression

Picture Yourself Shaking Up a Snow Globe and Watching What Unfolds Inside, Things Might Look Chaotic and Distorted at First, But as Things Start to Settle, a Clear View of a Picturesque Scene Emerges

This is how Dr. Carol Routledge tries to illustrate how the hallucinogenic drug DMT (dimethyltryptamine) could be used to drastically change the way people undergo therapy. As the chief …

Full story available on Benzinga.com

More Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week